News about the EORTC Liaison Offices in the United Kingdom and in France
11 Mar 2009
This month a new UK-based EORTC Liaison Officer, Liz Flackett (e.flackett[at]ncrn.org.uk), joined the EORTC Liaison Office in the UK. This Office is jointly supported by the EORTC, the National Cancer Research Network (NCRN) and Cancer Research UK (CRUK) has taken her position. In June, a Liaison Office in France will be set up in partnership between the EORTC and the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
These Liaison Offices are aimed at fostering collaborative clinical cancer research between the EORTC and other international cancer research organisations and also supporting EORTC members in order to facilitate administrative and regulatory aspects of conducting EORTC trials.
Related News
EORTC shines a light on advancements in radioligand therapy
8 Oct 2025
Treatment optimisation: making cancer treatment accessible and sustainable in Europe
24 Sep 2025
EORTC celebrates World Radiotherapy Awareness Day (WRAD) through innovation and collaboration in clinical cancer trials
3 Sep 2025
2148 MRD Study reaches milestone with First Patient In (FPI)
4 Aug 2025
PET imaging widely used in European brain tumour centres, survey shows
1 Jul 2025
New EORTC Leadership: President-Elect and Scientific Chairs Council
27 Jun 2025
First Site Activated in EU-Funded DE-ESCALATE Clinical Trial on Advanced Metastatic Prostate Cancer
10 Jun 2025
EORTC publishes its 2024 Annual Report: Driving progress in cancer treatment, together
4 Jun 2025
EORTC in the spotlight at ASCO 2025
4 Jun 2025
EORTC’s presence at ASCO 2025
28 May 2025